Overview

A Study to Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate

Status:
Completed
Trial end date:
2016-02-03
Target enrollment:
Participant gender:
Summary
This study evaluated the safety and efficacy of SM03 compared to placebo in patients with active rheumatoid arthritis(RA) receiving methotrexate
Phase:
Phase 2
Details
Lead Sponsor:
SinoMab Pty Ltd
Treatments:
Methotrexate